Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darexaban in Hip Fracture or Lower Extremity Surgery
NCT00937911Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of darexaban in venous thromboembolism (VTE), sponsored by Astellas Pharma. Started Jun 2009; status: completed.
02
Drugs
darexaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00937911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937911.